We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

62 hedge funds and large institutions have $53.6M invested in BioSpecifics Technologies Corp. in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

38% more funds holding

Funds holding: 45 → 62 (+17)

20% more capital invested

Capital invested by funds: $44.7M → $53.6M (+$8.88M)

Holders
62
Holders Change
+17
Holders Change %
+37.78%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
23
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$4.4M
2
BFA
BlackRock Fund Advisors
California
+$2.09M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.36M
4
Charles Schwab
Charles Schwab
California
+$1.08M
5
Morgan Stanley
Morgan Stanley
New York
+$866K

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$7.04M
2
BA
BlackRock Advisors
Delaware
-$814K
3
NC
Northpointe Capital
Michigan
-$744K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$416K
5
Franklin Resources
Franklin Resources
California
-$193K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$569K +$157K +6,011 +40%
NI
27
Numeric Investors
Massachusetts
$562K +$231K +8,863 +74%
TCIM
28
TIAA CREF Investment Management
New York
$513K +$496K +19,045 New
PAM
29
Paradigm Asset Management
New York
$501K +$13K +500 +3%
TAM
30
Tocqueville Asset Management
New York
$472K +$195K +7,500 +75%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$452K – – –
Jane Street
32
Jane Street
New York
$446K +$431K +16,555 New
ACM
33
Ativo Capital Management
Illinois
$390K – – –
Citadel Advisors
34
Citadel Advisors
Florida
$388K -$60.9K -2,337 -14%
GA
35
Geneva Advisors
Illinois
$376K -$181K -6,957 -33%
HIM
36
Hillsdale Investment Management
Ontario, Canada
$363K +$104K +4,000 +42%
PAI
37
Palo Alto Investors
California
$302K +$291K +11,184 New
Millennium Management
38
Millennium Management
New York
$277K +$267K +10,265 New
BIM
39
BlackRock Investment Management
Delaware
$272K +$263K +10,105 New
Calamos Advisors
40
Calamos Advisors
Illinois
$255K +$36.6K +1,404 +17%
SO
41
STRS Ohio
Ohio
$226K +$219K +8,400 New
Invesco
42
Invesco
Georgia
$199K +$191K +7,350 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$178K +$172K +6,600 New
SG Americas Securities
44
SG Americas Securities
New York
$143K +$138K +5,304 New
TA
45
Teachers Advisors
New York
$136K +$132K +5,049 New
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$101K +$1.95K +75 +2%
PA
47
Perceptive Advisors
New York
$100K +$96.4K +3,700 New
NFA
48
Nationwide Fund Advisors
Ohio
$71K +$69.1K +2,651 New
TRCT
49
Tower Research Capital (TRC)
New York
$70K +$62.5K +2,400 +1,182%
AIG
50
American International Group
New York
$64.1K +$61.9K +2,378 New
1
2
3

BSTC Hedge Fund Activity: Q2 2014 in Review

62 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2014, worth a combined $53.6M — up 20% from $44.7M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BSTC positions and 3 closed out — a net gain of 17 holders — while 23 added to existing stakes and 12 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $4.4M. The largest seller was Redmile Group, exiting entirely with an estimated $7.04M sold.

  • 62 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2014, up from 45 in Q1 2014.
  • Funds reported $53.6M of BioSpecifics Technologies Corp. stock for Q2 2014, up 20% quarter-over-quarter.
  • 20 funds opened new BioSpecifics Technologies Corp. positions in Q2 2014 and 3 closed out, a net change of +17 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2014 was Deerfield Management, an estimated $4.4M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2014 was Redmile Group, an estimated $7.04M sold.

Based on aggregated 13F filings for Q2 2014.